Home › Funds › Farallon Capital Management › BSX
Farallon Capital Management position in BSX
BOSTON SCIENTIFIC CORP · Health Care
Farallon Capital Management reported holding 11,287,164 shares of BSX (BOSTON SCIENTIFIC CORP) in its Q3 2026 13F filing — a position valued at US$492.7M, representing 2.18% of its reported portfolio and ranking #12 among its reported holdings. Farallon Capital Management has disclosed BSX holdings in 21 of the last 21 reported quarters, going back to Q3 2021.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Farallon Capital Management's BSX position evolved
Farallon Capital Management first disclosed a stake in BSX in Q3 2021 at 14,002,581 shares (US$607.6M). The position peaked in Q4 2021 at 16,814,581 shares, worth US$714.3M. Across 21 filings, Farallon Capital Management increased the stake 8 time(s), trimmed it 10 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 11,287,164 shares valued at US$492.7M — an increase of 765,980 shares quarter over quarter.. Notable position changes include a 35% trim in Q2 2023 (shares fell 2% over the following quarter), a 57% increase in Q4 2025 (shares fell 34% over the following quarter), a 41% increase in Q2 2026 (shares rose 2% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 14.00M | $607.57M | New |
| Q4 2021 | 16.81M | $714.28M | Add |
| Q1 2022 | 15.74M | $697.14M | Reduce |
| Q2 2022 | 15.05M | $560.81M | Reduce |
| Q3 2022 | 12.15M | $470.62M | Reduce |
| Q4 2022 | 9.26M | $428.47M | Reduce |
| Q1 2023 | 7.71M | $385.49M | Reduce |
| Q2 2023 | 5.05M | $272.90M | Reduce |
| Q3 2023 | 5.04M | $266.07M | Hold |
| Q4 2023 | 5.82M | $336.47M | Add |
| Q1 2024 | 4.60M | $314.83M | Reduce |
| Q2 2024 | 4.11M | $316.45M | Reduce |
| Q3 2024 | 5.43M | $454.67M | Add |
| Q4 2024 | 5.02M | $448.65M | Reduce |
| Q1 2025 | 3.76M | $379.59M | Reduce |
| Q2 2025 | 3.98M | $427.61M | Add |
| Q3 2025 | 4.75M | $463.41M | Add |
| Q4 2025 | 7.44M | $709.36M | Add |
| Q1 2026 | 7.47M | $468.79M | Hold |
| Q2 2026 | 10.52M | $449.04M | Add |
| Q3 2026 | 11.29M | $492.68M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About BSX and 13F data
BSX (BOSTON SCIENTIFIC CORP) is a Health Care company. 21 other funds we track also report a position in BSX — the largest reported positions include PRIMECAP MANAGEMENT CO/CA/ (US$2.56B), MFS Investment Management (US$2.29B), Arrowstreet Capital (US$1.24B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BSX
- PRIMECAP MANAGEMENT CO/CA/ 58.62M sh · $2.56B · Q3 2026
- MFS Investment Management 43.05M sh · $2.29B · Q3 2026
- Arrowstreet Capital 28.47M sh · $1.24B · Q3 2026
- AQR CAPITAL MANAGEMENT LLC 24.32M sh · $1.06B · Q3 2026
- AQR Capital Management 24.32M sh · $1.06B · Q3 2026
- Two Sigma Investments 20.01M sh · $873.30M · Q3 2026
More on Farallon Capital Management
FAQ
How long has Farallon Capital Management held BSX?
Farallon Capital Management has disclosed BSX holdings in 21 of the last 21 reported quarters, going back to Q3 2021.
What is Farallon Capital Management's current position in BSX?
As of Q3 2026, Farallon Capital Management holds 11.29M shares of BSX (BOSTON SCIENTIFIC CORP), valued at $492.68M, representing 2.18% of its reported portfolio and ranking #12.
Has Farallon Capital Management been buying or selling BSX?
In the latest 13F filing (Q3 2026), Farallon Capital Management increased its position in BSX. The position peaked in Q4 2021 at 16.81M shares.
Which other funds hold BSX?
Other major institutional holders of BSX include PRIMECAP MANAGEMENT CO/CA/, MFS Investment Management, Arrowstreet Capital, among 21 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.